Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4034)
All Articles published online
|
Jun 21, 2008 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kerem M, Ferahkose Z, Yilmaz UT, Pasaoglu H, Ofluoglu E, Bedirli A, Salman B, Sahin TT, Akin M. Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol 2008; 14(23): 3633-3641 [PMID: 18595130 DOI: 10.3748/wjg.14.3633] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i23/3633.htm |
| Number | Citing Articles |
| 1 |
Trude R. Balstad, Cinzia Brunelli, Caroline H. Pettersen, Svanhild A. Schønberg, Frank Skorpen, Marie Fallon, Stein Kaasa, Asta Bye, Barry J. A. Laird, Guro B. Stene, Tora S. Solheim. Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial. Frontiers in Nutrition 2021; 7 doi: 10.3389/fnut.2020.602775
|
| 2 |
Satoshi Ugi, Yoshihiko Nishio, Hiroshi Yamamoto, Kazuhiro Ikeda, Masaaki Kobayashi, Shuichi Tsukada, Motoyuki Kondo, Katsutaro Morino, Toshiyuki Obata, Takeshi Yoshizaki, Takashi Uzu, Hiroyuki Naitoh, Toru Tani, Shiro Maeda, Atsunori Kashiwagi, Hiroshi Maegawa. Relation of the Expression of Transcriptional Factor TFAP2B to That of Adipokines in Subcutaneous and Omental Adipose Tissues. Obesity 2010; 18(7): 1277 doi: 10.1038/oby.2009.442
|
| 3 |
S. Levolger, E. A. C. Wiemer, J. L. A. van Vugt, S. A. Huisman, M. G. van Vledder, S. van Damme-van Engel, G. Ambagtsheer, J. N. M. IJzermans, R. W. F. de Bruin. Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46178-9
|
| 4 |
Adeline Dolly, Jean‐François Dumas, Stéphane Servais. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?. Journal of Cachexia, Sarcopenia and Muscle 2020; 11(6): 1413 doi: 10.1002/jcsm.12633
|
| 5 |
Flavia Prodam, Nicoletta Filigheddu. Ghrelin Gene Products in Acute and Chronic Inflammation. Archivum Immunologiae et Therapiae Experimentalis 2014; 62(5): 369 doi: 10.1007/s00005-014-0287-9
|
| 6 |
L.M. Freeman. Cachexia and Sarcopenia: Emerging Syndromes of Importance in Dogs and Cats. Journal of Veterinary Internal Medicine 2012; 26(1): 3 doi: 10.1111/j.1939-1676.2011.00838.x
|
| 7 |
E. V. Semina, N. V. Danilova, N. A. Oleinikova, M. A. Agapov, K. A. Rubina. THE RELATIONSHIP BETWEEN METABOLIC DISORDERS AND TUMOR PROGRESSION: REVIEW OF PRESENT DATA AND NEW THERAPEUTIC TARGETS. Siberian journal of oncology 2021; 20(4): 130 doi: 10.21294/1814-4861-2021-20-4-130-145
|
| 8 |
Yunbao Pan, Fuling Zhou, Chenyan He, Lingyun Hui, Tianhe Huang, Yongchang Wei. Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6482842
|
| 9 |
Ioannis Gioulbasanis, Athanasios Pallis, Panagiotis J. Vlachostergios, Alexandros Xyrafas, Zoe Giannousi, Isidora-Eleni Perdikouri, Michalitsa Makridou, Dionysia Kakalou, Vassilios Georgoulias. The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer. Lung Cancer 2012; 77(2): 383 doi: 10.1016/j.lungcan.2012.04.008
|
| 10 |
Hisao Imai, Takayuki Kishikawa, Hiroyuki Minemura, Yutaka Yamada, Tatsuya Ibe, Ou Yamaguchi, Atsuto Mouri, Yoichiro Hamamoto, Kenya Kanazawa, Takashi Kasai, Kyoichi Kaira, Takayuki Kaburagi, Koichi Minato, Kunihiko Kobayashi, Hiroshi Kagamu. Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer. Cancer Medicine 2021; 10(20): 6971 doi: 10.1002/cam4.4220
|
| 11 |
Takashi Akamizu, Kenji Kangawa. Ghrelin for cachexia. Journal of Cachexia, Sarcopenia and Muscle 2010; 1(2): 169 doi: 10.1007/s13539-010-0011-5
|
| 12 |
Renata Silvério, Fábio S. Lira, Lila M. Oyama, Cláudia M. Oller do Nascimento, José P. Otoch, Paulo S. M. Alcântara, Miguel L. Batista, Marília Seelaender. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0547-x
|
| 13 |
Zhenzhen Zhang, Jackilen Shannon, Hanrui Zhang. Adipocytokines, Energy Balance, and Cancer. Energy Balance and Cancer 2017; 12: 187 doi: 10.1007/978-3-319-41677-9_9
|
| 14 |
Paraskevi Boura, Stylianos Loukides, Dimitra Grapsa, Apostolos Achimastos, Konstantinos Syrigos. The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives. Future Oncology 2015; 11(15): 2193 doi: 10.2217/fon.15.96
|
| 15 |
Mohammadamin Sadeghi, Mahsa Keshavarz-Fathi, Vickie Baracos, Jann Arends, Maryam Mahmoudi, Nima Rezaei. Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology/Hematology 2018; 127: 91 doi: 10.1016/j.critrevonc.2018.05.006
|
| 16 |
Norimitsu Kasahara, Hisao Imai, Ichiro Naruse, Yusuke Tsukagoshi, Mie Kotake, Noriaki Sunaga, Kyoichi Kaira, Toshitaka Maeno, Takayuki Asao, Takeshi Hisada. Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment. Thoracic Cancer 2020; 11(8): 2188 doi: 10.1111/1759-7714.13526
|
| 17 |
Paraskevi Boura, Dimitra Grapsa, Stylianos Loukides, Maria Angelidou, Konstantina Tsakanika, Nikolaos Syrigos, Ioannis Gkiozos. The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer. Lung Cancer Management 2017; 6(2): 55 doi: 10.2217/lmt-2016-0018
|
| 18 |
J.T Dwarkasing, D.L. Marks, R.F Witkamp, K. van Norren. Hypothalamic inflammation and food intake regulation during chronic illness. Peptides 2016; 77: 60 doi: 10.1016/j.peptides.2015.06.011
|
| 19 |
Oliver Grundmann, Saunjoo L. Yoon, Joseph J. Williams. Handbook of Famine, Starvation, and Nutrient Deprivation. 2019; : 943 doi: 10.1007/978-3-319-55387-0_56
|
| 20 |
Annika Ritz, Eberhard Lurz, Michael Berger. Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era. Cells 2022; 11(8): 1278 doi: 10.3390/cells11081278
|
| 21 |
Yu-Ching Lin, Cheng-Hsu Wang, Hang Huong Ling, Yi-Ping Pan, Pei-Hung Chang, Wen-Chi Chou, Fang-Ping Chen, Kun-Yun Yeh. Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy. Biomedicines 2022; 10(2): 388 doi: 10.3390/biomedicines10020388
|
| 22 |
Dorota Diakowska, Krystyna Markocka-Mączka, Piotr Szelachowski, Krzysztof Grabowski. Serum Levels of Resistin, Adiponectin, and Apelin in Gastroesophageal Cancer Patients. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/619649
|
| 23 |
Michael J Tisdale. Cancer cachexia. Current Opinion in Gastroenterology 2010; 26(2): 146 doi: 10.1097/MOG.0b013e3283347e77
|
| 24 |
Oliver Grundmann, Saunjoo L. Yoon, Joseph J. Williams. Handbook of Famine, Starvation, and Nutrient Deprivation. 2017; : 1 doi: 10.1007/978-3-319-40007-5_56-1
|
| 25 |
Josep M Argilés, Britta Stemmler. The potential of ghrelin in the treatment of cancer cachexia. Expert Opinion on Biological Therapy 2013; 13(1): 67 doi: 10.1517/14712598.2013.727390
|
| 26 |
Lisa K. Chopin, Inge Seim, Carina M. Walpole, Adrian C. Herington. The Ghrelin Axis—Does It Have an Appetite for Cancer Progression?. Endocrine Reviews 2012; 33(6): 849 doi: 10.1210/er.2011-1007
|
| 27 |
N. JOHNS, B. H. TAN, M. MACMILLAN, T. S. SOLHEIM, J. A. ROSS, V. E. BARACOS, S. DAMARAJU, K. C. H. FEARON. Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies. Journal of Genetics 2014; 93(3): 893 doi: 10.1007/s12041-014-0405-9
|
| 28 |
Joanna Smiechowska, Anne Utech, George Taffet, Teresa Hayes, Marco Marcelli, José M. Garcia. Adipokines in Patients with Cancer Anorexia and Cachexia. Journal of Investigative Medicine 2010; 58(3): 554 doi: 10.2310/JIM.0b013e3181cf91ca
|
| 29 |
H. Suzuki, A. Asakawa, H. Amitani, N. Fujitsuka, N. Nakamura, A. Inui. Cancer Cachexia Pathophysiology and Translational Aspect of Herbal Medicine. Japanese Journal of Clinical Oncology 2013; 43(7): 695 doi: 10.1093/jjco/hyt075
|
| 30 |
Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, Koh Furuta, Ichiro Oda, Hoichi Kato, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada. Adipocytokines and squamous cell carcinoma of the esophagus. Journal of Cancer Research and Clinical Oncology 2010; 136(2): 261 doi: 10.1007/s00432-009-0657-6
|
| 31 |
Jeremy Steinman, Mark Daniel DeBoer. Anorexia. Vitamins & Hormones 2013; 92: 197 doi: 10.1016/B978-0-12-410473-0.00008-8
|
| 32 |
Shailendra Kapoor. Re: Jehonathan H. Pinthus, Nir Kleinmann, Britton Tisdale, et al. Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney. Eur Urol 2008;54:866–74. European Urology 2009; 55(3): e52 doi: 10.1016/j.eururo.2008.08.073
|
| 33 |
Takahiro Nishida, Hironobu Tsubouchi, Takeomi Hamada, Naoya Imamura, Masahide Hiyoshi, Koichi Yano, Kenji Kangawa, Masamitsu Nakazato, Atsushi Nanashima. Plasma desacyl ghrelin‑to‑acyl ghrelin ratio is a predictor of postoperative complications and prognosis after pancreaticoduodenectomy. Oncology Letters 2019; doi: 10.3892/ol.2019.10821
|
| 34 |
Alexander D. Heini, Rebecca Hugo, Martin D. Berger, Urban Novak, Ulrike Bacher, Thomas Pabst. Simple acute phase protein score to predict long‐term survival in patients with acute myeloid leukemia. Hematological Oncology 2020; 38(1): 74 doi: 10.1002/hon.2696
|
| 35 |
Amos Hung, Yen-Yun Wang, Kun-Tsung Lee, Hung-Hsing Chiang, Yuk-Kwan Chen, Je-Kang Du, Chun-Ming Chen, Michael Chen, Kwei-Jing Chen, Stephen Hu, Shyng-Shiou Yuan. Reduced tissue and serum resistin expression as a clinical marker for esophageal squamous cell carcinoma. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13035
|
| 36 |
Arjun Gupta, Yehuda Herman, Colby Ayers, Muhammad S. Beg, Susan G. Lakoski, Shuaib M. Abdullah, David H. Johnson, Ian J. Neeland, David Meyre. Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study. PLOS ONE 2016; 11(9): e0162845 doi: 10.1371/journal.pone.0162845
|
| 37 |
Oliver Grundmann, Saunjoo L. Yoon, Joseph J. Williams. Cachexia in Patients with Gastrointestinal Cancers: Contributing Factors, Prevention, and Current Management Approaches. EMJ Gastroenterology 2020; : 62 doi: 10.33590/emjgastroenterol/20-00181
|
| 38 |
M.L. Batista, M. Olivan, P.S.M. Alcantara, R. Sandoval, S.B. Peres, R.X. Neves, R. Silverio, L.F. Maximiano, J.P. Otoch, M. Seelaender. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine 2013; 61(2): 532 doi: 10.1016/j.cyto.2012.10.023
|
| 39 |
Yuki Akazawa, Satoshi Igawa, Kaori Yamada, Hiroki Yamamoto, Yuri Yagami, Nobuki Kaizuka, Hiroya Manaka, Masashi Kasajima, Yoshiro Nakahara, Takashi Sato, Hisashi Mitsufuji, Masanori Yokoba, Masaru Kubota, Jiichiro Sasaki, Katsuhiko Naoki. The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. Oncology 2023; 101(11): 685 doi: 10.1159/000530809
|
| 40 |
Julia B. Ewaschuk, Alaa Almasud, Vera C. Mazurak. Role of n-3 fatty acids in muscle loss and myosteatosis. Applied Physiology, Nutrition, and Metabolism 2014; 39(6): 654 doi: 10.1139/apnm-2013-0423
|
| 41 |
Takashi Akamizu, Kenji Kangawa. Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect. Peptides 2011; 32(11): 2295 doi: 10.1016/j.peptides.2011.05.018
|
| 42 |
Donald C. McMillan. The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treatment Reviews 2013; 39(5): 534 doi: 10.1016/j.ctrv.2012.08.003
|
| 43 |
Fabio Penna, Gabriella Bonelli, Francesco M. Baccino, Paola Costelli. Anorexia. Vitamins & Hormones 2013; 92: 271 doi: 10.1016/B978-0-12-410473-0.00011-8
|
| 44 |
Kent Lundholm, Lena Gunnebo, Ulla Körner, Britt‐Marie Iresjö, Cecilia Engström, Anders Hyltander, Ulrika Smedh, Ingvar Bosaeus. Effects by daily long term provision of ghrelin to unselected weight‐losing cancer patients. Cancer 2010; 116(8): 2044 doi: 10.1002/cncr.24917
|
| 45 |
Ross D Dolan, Stephen T McSorley, Paul G Horgan, Barry Laird, Donald C McMillan. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysis. Critical Reviews in Oncology/Hematology 2017; 116: 134 doi: 10.1016/j.critrevonc.2017.06.002
|
| 46 |
Jéssica V. Mansson, Fernanda D. Alves, Andréia Biolo, Gabriela C. Souza. Use of ghrelin in cachexia syndrome: a systematic review of clinical trials. Nutrition Reviews 2016; 74(11): 659 doi: 10.1093/nutrit/nuw029
|
| 47 |
Rita Nogueira-Ferreira, Fábio Sousa-Nunes, Adelino Leite-Moreira, Liliana Moreira-Costa, Rui Vitorino, Lúcio Lara Santos, Daniel Moreira-Gonçalves, Rita Ferreira. Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?. Inflammation Research 2022; 71(7-8): 771 doi: 10.1007/s00011-022-01586-y
|
| 48 |
Josep M. Argilés, Britta Stemmler, Francisco J. López-Soriano, Silvia Busquets. Nonmuscle Tissues Contribution to Cancer Cachexia. Mediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/182872
|
| 49 |
Julia Geppert, Maria Rohm. Cancer cachexia: biomarkers and the influence of age. Molecular Oncology 2024; doi: 10.1002/1878-0261.13590
|
| 50 |
Sumanta Dutta, Andrew B.C. Crumley, Grant M. Fullarton, Paul G. Horgan, Donald C. McMillan. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. The American Journal of Surgery 2012; 204(3): 294 doi: 10.1016/j.amjsurg.2011.10.015
|
| 51 |
BENJAMIN H. L. TAN, JAMES A. ROSS, STEIN KAASA, FRANK SKORPEN, KENNETH C. H. FEARON. Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review. Journal of Genetics 2011; 90(1): 165 doi: 10.1007/s12041-011-0027-4
|
| 52 |
Tania Setiawan, Ita Novita Sari, Yoseph Toni Wijaya, Nadya Marcelina Julianto, Jabir Aliyu Muhammad, Hyeok Lee, Ji Heon Chae, Hyog Young Kwon. Cancer cachexia: molecular mechanisms and treatment strategies. Journal of Hematology & Oncology 2023; 16(1) doi: 10.1186/s13045-023-01454-0
|
| 53 |
Dexing Wang, Li Duan, Zhiquan Tu, Fei Yan, Cuicui Zhang, Xu Li, Yuzhu Cao, Hongsheng Wen. The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer. Chemotherapy 2016; 61(4): 217 doi: 10.1159/000443367
|
| 54 |
Magdalena Schab, Szymon Skoczen. The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer. International Journal of Molecular Sciences 2022; 23(9): 5159 doi: 10.3390/ijms23095159
|
| 55 |
Donald C McMillan. Systemic inflammation, nutritional status and survival in patients with cancer. Current Opinion in Clinical Nutrition and Metabolic Care 2009; 12(3): 223 doi: 10.1097/MCO.0b013e32832a7902
|
| 56 |
Kazuki Abe, Kaito Shibata, Takafumi Naito, Atsushi Otsuka, Masato Karayama, Masato Maekawa, Hideaki Miyake, Takafumi Suda, Junichi Kawakami. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients. European Journal of Clinical Pharmacology 2022; 78(1): 77 doi: 10.1007/s00228-021-03199-6
|
| 57 |
Ilze Strumfa, Tatjana Bogdanova, Arturs Kalva, Boriss Strumfs, Roberts Rumba, Andrejs Vanags, Inese Drike, Dzeina Mezale, Arnis Abolins, Arvids Jakovlevs, Dainis Balodis, Janis Gardovskis. Gastric Cancer. 2017; doi: 10.5772/intechopen.69723
|
| 58 |
Tomoya Tsukada, Sachio Fushida, Shinichi Harada, Shiroh Terai, Yasumichi Yagi, Jun Kinoshita, Katsunobu Oyama, Hidehiro Tajima, Hideto Fujita, Itasu Ninomiya, Takashi Fujimura, Tetsuo Ohta. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. Journal of Experimental & Clinical Cancer Research 2011; 30(1) doi: 10.1186/1756-9966-30-107
|
| 59 |
Theodora Tzanavari, Jason Tasoulas, Chrysoula Vakaki , Chrysovalantou Mihailidou , Gerasimos Tsourouflis , Stamatios Theocharis . The Role of Adipokines in the Establishment and Progression of Head and Neck Neoplasms. Current Medicinal Chemistry 2019; 26(25): 4726 doi: 10.2174/0929867325666180713154505
|
| 60 |
Suzanne W. Chang, William S. Pan, Daniel Lozano Beltran, Lizet Oleyda Baldelomar, Marco Antonio Solano, Iskra Tuero, Jon S. Friedland, Faustino Torrico, Robert H. Gilman, Robert J. Wilkinson. Gut Hormones, Appetite Suppression and Cachexia in Patients with Pulmonary TB. PLoS ONE 2013; 8(1): e54564 doi: 10.1371/journal.pone.0054564
|
| 61 |
R Dev, E. Bruera, S. Dalal. Insulin resistance and body composition in cancer patients. Annals of Oncology 2018; 29: ii18 doi: 10.1093/annonc/mdx815
|
| 62 |
Josep M. Argilés, Britta Stemmler, Francisco J. López-Soriano, Silvia Busquets. Inter-tissue communication in cancer cachexia. Nature Reviews Endocrinology 2019; 15(1): 9 doi: 10.1038/s41574-018-0123-0
|
| 63 |
Maria Dalamaga. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomarkers in Medicine 2014; 8(1): 107 doi: 10.2217/bmm.13.99
|
| 64 |
Elisavet K. Tiaka, Anastassios C. Manolakis, Andreas N. Kapsoritakis, Spyros P. Potamianos. The implication of adiponectin and resistin in gastrointestinal diseases. Cytokine & Growth Factor Reviews 2011; 22(2): 109 doi: 10.1016/j.cytogfr.2011.04.002
|
| 65 |
Michele Mannelli, Tania Gamberi, Francesca Magherini, Tania Fiaschi. The Adipokines in Cancer Cachexia. International Journal of Molecular Sciences 2020; 21(14): 4860 doi: 10.3390/ijms21144860
|
| 66 |
Ying Liu, Pedro Saavedra, Norbert Perrimon. Cancer cachexia: lessons from Drosophila
. Disease Models & Mechanisms 2022; 15(3) doi: 10.1242/dmm.049298
|
| 67 |
Seidamir Pasha TABAEIAN, Touraj MAHMOUDI, Gholamreza REZAMAND, Hossein NOBAKHT, Reza DABIRI, Hamid FARAHANI, Asadollah ASADI, Mohammad Reza ZALI. RESISTIN GENE POLYMORPHISM AND NONALCOHOLIC FATTY LIVER DISEASE RISK. Arquivos de Gastroenterologia 2022; 59(4): 483 doi: 10.1590/s0004-2803.202204000-86
|
| 68 |
Takako Eguchi Nakajima, Yasuhide Yamada, Tetsutaro Hamano, Koh Furuta, Takuji Gotoda, Hitoshi Katai, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. Journal of Gastroenterology 2009; 44(7): 685 doi: 10.1007/s00535-009-0063-5
|
| 69 |
Josep M. Argilés, Sílvia Busquets, Britta Stemmler, Francisco J. López-Soriano. Cancer cachexia: understanding the molecular basis. Nature Reviews Cancer 2014; 14(11): 754 doi: 10.1038/nrc3829
|
| 70 |
Satoshi Wasamoto, Hisao Imai, Takeshi Tsuda, Yoshiaki Nagai, Hiroyuki Minemura, Yutaka Yamada, Yukihiro Umeda, Takayuki Kishikawa, Ayako Shiono, Yuki Kozu, Jun Shiihara, Ou Yamaguchi, Atsuto Mouri, Kyoichi Kaira, Kenya Kanazawa, Hirokazu Taniguchi, Takayuki Kaburagi, Koichi Minato, Hiroshi Kagamu. Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1080729
|